31st March 2020 – Global ePharmacyMarket report offers the latest industry trends, technological
alteration and forecast data. A deep-dive view of ePharmacy industry based on
its size, growth, development plans, and opportunities is offered by this
report. The forecast information, SWOT analysis, ePharmacy barriers, and
feasibility study are the vital aspects evaluated in this report.
Market Tidbits:
The scope of the global ePharmacy
Market was appreciated at US$ 33.03 billion in 2016. The range is projected to
touch US$ 109.2 billion by 2025, growing at a CAGR of 14.8% for the duration of
the forecast.
This is attributed to the upsurge in
pharmaceutical products’ sale through electronic media. The use of Internet has
been increasing at an alarming rate in the present scenario. Besides, rise in
geriatric population calls for availability of medicines at the doorstep. This
is another factor bolstering the e-Pharma market.
Request
a Sample Copy @ https://www.millioninsights.com/industry-reports/epharmacy-market/request-sample
Main features of the report:
·
To provide detailed analysis of
the market structure along with forecast of the various segments and
sub-segments of the global ePharmacy Market.
·
A complete backdrop analysis,
which includes an assessment of the parent market
·
Important changes in market
dynamics
·
Market segmentation up to the
second or third level
·
To provide country level
analysis of the market for segment by application, product type and
sub-segments.
·
To provide strategic profiling
of key players in the market, comprehensively analyzing their core
competencies, and drawing a competitive landscape for the market.
·
Track and analyze competitive
developments such as joint ventures, strategic alliances, mergers and
acquisitions, new product developments, and research and developments in the
global ePharmacy Market.
·
Emerging niche segments and
regional markets
·
An objective assessment of the
trajectory of the industry.
Market Segmentation:
The ePharmacy market is segmented based
on mode and geography. By mode, it comprises direct and aggregator. By
geography, the segmentation goes like North America (U.S., Mexico, and Canada),
Europe (France, UK, Italy, Russia, Germany, and the rest of Europe), LATAM
(Columbia, Argentina, Brazil, and the rest of LATAM), Asia Pacific (Japan,
China, South Korea, Southeast Asia, India, and the rest of Asia Pacific), and
MEA (Nigeria, Egypt, UAE, Saudi Arabia, and rest of MEA). North America leads
the market; thanks to immediate adoption of advanced technology coupled with
extensive spending on healthcare. Asia Pacific comes in second; with India
being the torchbearer.
Indian market on the roll:
India is into rapid adoption of
e-Commerce with improvement in digital payments’ infrastructure and
mobile-first consumer behavior. Plus, government is increasingly focusing on
quicker adoption of internet and healthcare spending. This is bound to not only
add to the value for customers but also create loads of B2B opportunities
henceforth. The verticals like fintech, consumer tech, e-Commerce, and
hyperlocal space are looking upon e-Pharma as a promising investment in India
as well as globally.
Indian players also have omnichannel
presence; especially in the emerging tier-2 or tier-3 towns who are hands on
with healthcare spending. This factor is also likely to boost the ePharmacy
industry all over.
Players:
The players contributing to the
ePharmacy market include Aurobindo Pharma, Doc Morris, Boehringer Ingelheim,
AbbVie Contract Manufacturing, Express Scripts Holding Company, Walmart Stores,
Inc., Pfizer Centre Source, Optum Rx, Inc., Walgreen Co., CVS Health, Inc., and
Giant Eagle.
At Million Insights, we work with the
aim to reach the highest levels of customer satisfaction. Our representatives
strive to understand diverse client requirements and cater to the same with the
most innovative and functional solutions.
For
More Information, Visit @ https://www.millioninsights.com
No comments:
Post a Comment